These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


187 related items for PubMed ID: 9149102

  • 1. Effect of chronic antipsychotic drug treatment on preprosomatostatin and preprotachykinin A mRNA levels in the medial prefrontal cortex, the nucleus accumbens and the caudate putamen of the rat.
    Marcus MM, Nomikos GG, Malmerfelt A, Zachrisson O, Lindefors N, Svensson TH.
    Brain Res Mol Brain Res; 1997 May; 45(2):275-82. PubMed ID: 9149102
    [Abstract] [Full Text] [Related]

  • 2. Subchronic administration of clozapine, but not haloperidol or metoclopramide, decreases dopamine D2 receptor messenger RNA levels in the nucleus accumbens and caudate-putamen in rats.
    See RE, Lynch AM, Sorg BA.
    Neuroscience; 1996 May; 72(1):99-104. PubMed ID: 8730709
    [Abstract] [Full Text] [Related]

  • 3. Effect of antipsychotic drugs on extracellular serotonin levels in rat medial prefrontal cortex and nucleus accumbens.
    Ichikawa J, Kuroki T, Dai J, Meltzer HY.
    Eur J Pharmacol; 1998 Jun 19; 351(2):163-71. PubMed ID: 9686999
    [Abstract] [Full Text] [Related]

  • 4. ACP-103, a 5-HT2A/2C inverse agonist, potentiates haloperidol-induced dopamine release in rat medial prefrontal cortex and nucleus accumbens.
    Li Z, Ichikawa J, Huang M, Prus AJ, Dai J, Meltzer HY.
    Psychopharmacology (Berl); 2005 Dec 19; 183(2):144-53. PubMed ID: 16220333
    [Abstract] [Full Text] [Related]

  • 5. Effects of risperidone and haloperidol on tachykinin and opioid precursor peptide mRNA levels in the caudate-putamen and nucleus accumbens of the rat.
    Mijnster MJ, Schotte A, Docter GJ, Voorn P.
    Synapse; 1998 Apr 19; 28(4):302-12. PubMed ID: 9517839
    [Abstract] [Full Text] [Related]

  • 6. Neuroleptics increase c-fos expression in the forebrain: contrasting effects of haloperidol and clozapine.
    Robertson GS, Fibiger HC.
    Neuroscience; 1992 Apr 19; 46(2):315-28. PubMed ID: 1347406
    [Abstract] [Full Text] [Related]

  • 7. Dopamine D3 receptors are not involved in the induction of c-fos mRNA by neuroleptic drugs: comparison of the dopamine D3 receptor antagonist GR103691 with typical and atypical neuroleptics.
    Hurley MJ, Stubbs CM, Jenner P, Marsden CD.
    Eur J Pharmacol; 1996 Dec 30; 318(2-3):283-93. PubMed ID: 9016916
    [Abstract] [Full Text] [Related]

  • 8. Effects of antipsychotic drugs on extracellular dopamine levels in rat medial prefrontal cortex and nucleus accumbens.
    Kuroki T, Meltzer HY, Ichikawa J.
    J Pharmacol Exp Ther; 1999 Feb 30; 288(2):774-81. PubMed ID: 9918588
    [Abstract] [Full Text] [Related]

  • 9. Differential regulation of neuropeptide mRNA expression in intrastriatal striatal transplants by host dopaminergic afferents.
    Campbell K, Wictorin K, Björklund A.
    Proc Natl Acad Sci U S A; 1992 Nov 01; 89(21):10489-93. PubMed ID: 1438238
    [Abstract] [Full Text] [Related]

  • 10. Differential effects of chronic treatment with haloperidol and clozapine on the level of preprosomatostatin mRNA in the striatum, nucleus accumbens, and frontal cortex of the rat.
    Salin P, Mercugliano M, Chesselet MF.
    Cell Mol Neurobiol; 1990 Mar 01; 10(1):127-44. PubMed ID: 1970756
    [Abstract] [Full Text] [Related]

  • 11. Comparison of basal and D-1 dopamine receptor agonist-stimulated neuropeptide gene expression in caudate-putamen and nucleus accumbens of ad libitum fed and food-restricted rats.
    Haberny SL, Carr KD.
    Brain Res Mol Brain Res; 2005 Nov 30; 141(2):121-7. PubMed ID: 16257473
    [Abstract] [Full Text] [Related]

  • 12. Systemic administration of amperozide, a new atypical antipsychotic drug, preferentially increases dopamine release in the rat medial prefrontal cortex.
    Nomikos GG, Iurlo M, Andersson JL, Kimura K, Svensson TH.
    Psychopharmacology (Berl); 1994 Jun 30; 115(1-2):147-56. PubMed ID: 7862887
    [Abstract] [Full Text] [Related]

  • 13. Differential effects of locally administered clozapine and haloperidol on dopamine efflux in the rat prefrontal cortex and caudate-putamen.
    Pehek EA, Yamamoto BK.
    J Neurochem; 1994 Dec 30; 63(6):2118-24. PubMed ID: 7964731
    [Abstract] [Full Text] [Related]

  • 14. Region-specific induction of deltaFosB by repeated administration of typical versus atypical antipsychotic drugs.
    Atkins JB, Chlan-Fourney J, Nye HE, Hiroi N, Carlezon WA, Nestler EJ.
    Synapse; 1999 Aug 30; 33(2):118-28. PubMed ID: 10400890
    [Abstract] [Full Text] [Related]

  • 15. Risperidone: regional effects in vivo on release and metabolism of dopamine and serotonin in the rat brain.
    Hertel P, Nomikos GG, Iurlo M, Svensson TH.
    Psychopharmacology (Berl); 1996 Mar 30; 124(1-2):74-86. PubMed ID: 8935802
    [Abstract] [Full Text] [Related]

  • 16. SR46349-B, a 5-HT(2A/2C) receptor antagonist, potentiates haloperidol-induced dopamine release in rat medial prefrontal cortex and nucleus accumbens.
    Bonaccorso S, Meltzer HY, Li Z, Dai J, Alboszta AR, Ichikawa J.
    Neuropsychopharmacology; 2002 Sep 30; 27(3):430-41. PubMed ID: 12225700
    [Abstract] [Full Text] [Related]

  • 17. Co-localization of preprosomatostatin mRNA and preprotachykinin A mRNA in neurons of the rat suprachiasmatic nucleus.
    Shigeyoshi Y, Maebayashi Y, Okamura H.
    Brain Res Mol Brain Res; 1997 Aug 30; 48(1):159-63. PubMed ID: 9379838
    [Abstract] [Full Text] [Related]

  • 18. Induction of c-fos mRNA in rat medial prefrontal cortex by antipsychotic drugs: role of dopamine D2 and D3 receptors.
    Merchant KM, Figur LM, Evans DL.
    Cereb Cortex; 1996 Aug 30; 6(4):561-70. PubMed ID: 8670682
    [Abstract] [Full Text] [Related]

  • 19. 5-HT(1A) and 5-HT(2A) receptors minimally contribute to clozapine-induced acetylcholine release in rat medial prefrontal cortex.
    Ichikawa J, Dai J, Meltzer HY.
    Brain Res; 2002 Jun 07; 939(1-2):34-42. PubMed ID: 12020849
    [Abstract] [Full Text] [Related]

  • 20. Aripiprazole, a novel antipsychotic drug, preferentially increases dopamine release in the prefrontal cortex and hippocampus in rat brain.
    Li Z, Ichikawa J, Dai J, Meltzer HY.
    Eur J Pharmacol; 2004 Jun 16; 493(1-3):75-83. PubMed ID: 15189766
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 10.